Australia markets closed

Neurogene Inc. (NGNE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
42.59+0.60 (+1.43%)
At close: 04:00PM EDT
42.80 +0.21 (+0.49%)
After hours: 07:32PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-40,975
-36,317
-55,189
-50,517
Depreciation & amortisation
3,304
3,297
3,200
947
Stock-based compensation
2,170
1,418
1,252
896
Change in working capital
-8,209
-4,023
-2,695
1,595
Accounts payable
-23
667
-3,607
2,982
Other working capital
-59,874
-51,743
-55,054
-64,769
Other non-cash items
-15,347
-15,692
608
679
Net cash provided by operating activities
-59,517
-51,422
-52,824
-46,400
Cash flows from investing activities
Investments in property, plant and equipment
-357
-321
-2,230
-18,369
Sales/maturities of investments
35,000
5,000
0
-
Other investing activities
-
20,958
-
-
Net cash used for investing activities
55,601
25,637
-2,230
-18,369
Cash flows from financing activities
Debt repayment
-35
-29
-1
0
Common stock issued
-
92,343
0
-
Net cash used provided by (used for) financing activities
85,851
92,482
66,531
51,063
Net change in cash
81,935
66,697
11,477
-13,706
Cash at beginning of period
68,544
82,021
70,544
84,250
Cash at end of period
150,479
148,718
82,021
70,544
Free cash flow
Operating cash flow
-59,517
-51,422
-52,824
-46,400
Capital expenditure
-357
-321
-2,230
-18,369
Free cash flow
-59,874
-51,743
-55,054
-64,769